Aviva (AIVAF) Research & Development: $0 Mil (TTM As of Dec. 2025)


AIVAF Aviva PLC AIVAF
58 GF Score
Price $8.45
GF Value $11.30
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Aviva Research & Development?

Aviva AIVAF 58 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates AIVAF with a GF Score™ of 58/100 and a GF Value™ of $11.30 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aviva's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Aviva  (OTCPK:AIVAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aviva Research & Development Related Terms

Aviva Research & Development Historical Data

* Premium members only.

The historical data trend for Aviva's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aviva Research & Development Chart

Aviva Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aviva Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AIVAF
58GF Score
Aviva PLC AIVAF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aviva Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Aviva (AIVAF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Aviva and its competitors.
Is Aviva's Research & Development too high?
Aviva's current Research & Development is $0 Mil. Overall, Aviva has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aviva's Research & Development compare to BRK.A and AIG?
Aviva's Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aviva and its competitors. Aviva's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aviva stock overvalued right now?
Based on GuruFocus' analysis, Aviva (AIVAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.30, compared to a current price of $8.45 — trading 25.2% below its estimated fair value. The current Research & Development is $0 Mil. Aviva's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aviva (AIVAF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aviva (AIVAF) Overvalued in 2026?

Based on GuruFocus' analysis, Aviva stock appears to be undervalued. The current stock price of $8.45 is trading 25.2% below its estimated GF Value™ of $11.30. GuruFocus considers Aviva to be Modestly Undervalued.

Key valuation signals for AIVAF:

  • Research & Development: $0 Mil
  • GF Value™: $11.30 vs. price of $8.45 (25.2% below fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the AIVAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aviva Business Description

Address 80 Fenchurch Street, London, GBR, EC3M 4AE
Aviva is a multiline insurer listed on the London Stock Exchange. The company traces its roots back to the 17th century with the establishment of Hand in Hand. After the Great Fire of London, this mutual was formed to provide protection against fires. Hand in Hand was then acquired in 1905 by Commercial Union. Over the years, Hand in Hand insured London landmarks such as London Bridge, the British Museum, and Lambeth Palace. The life insurance part of Aviva began in the early part of the 18th century with the establishment of Amicable, also a mutual, but this time to protect widows and children against loss of life and loss of income.
58GF Score

Get the complete analysis for AIVAF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.45
Price
$11.30
GF Value